Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-31

You are forgetting about the MDMA & psilocybin treatment the company will offer my friend. I agree this share will probably not hit $1 any time soon, But with the next few quarterlies being released on top of the results of their study/licencing, you can turn a nice profit. I believe this company is on a path of redemption and with the increasing turnover and reduced outlay, I expect to see then cash flow neutral in the near future which is what the company needs so that investors can regain confidence in this company rather than thinking it as just a pump and dump.